← Back to Clinical Trials
Recruiting NCT07290556

NCT07290556 Establishing the Preliminary Utility of a Novel Pediatric Manual Mobile Standing Wheelchair

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07290556
Status Recruiting
Phase
Sponsor Optimal Mobility, Inc
Condition Spina Bifida
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2026-06-18
Primary Completion 2027-08-25

Eligibility & Interventions

Sex All sexes
Min Age 8 Years
Max Age 17 Years
Study Type INTERVENTIONAL
Interventions
PedMMSWC Wheelchair User TestingPedMMSWC Simulated Home, School, Community Environment

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2026-06-18 with a primary completion date of 2027-08-25.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

To establish the preliminary utility of a novel pediatric manual mobile standing wheelchair (PedMMSWC).

Eligibility Criteria

Inclusion Criteria: * 8 - 17 years old * Primarily use a manual wheelchair for daily mobility * Are actively enrolled in a standing program * Fit the height and weight requirements of the PedMMSWC * Can follow simple verbal instructions * Are able to speak and read in English Exclusion Criteria: * Have insufficient trunk control to maneuver in seated and standing positions * Have lower limb contracture which would preclude standing * Have had orthopedic surgery within the last twelve months * Have pressure injuries at the location where the PedMMSWC interfaces * Have insufficient fine motor skills to independently initiate the sit-to-stand function * Have a history of uncontrolled seizures or cardiovascular conditions that would make participation unsafe

Contact & Investigator

Central Contact

Patricia McCraken, DPT, MBA

✉ pmccraken@optimal-mobility.com

📞 320-247-2104

Frequently Asked Questions

Who can join the NCT07290556 clinical trial?

This trial is open to participants of all sexes, aged 8 Years or older, up to 17 Years, studying Spina Bifida. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07290556 currently recruiting?

Yes, NCT07290556 is actively recruiting participants. Contact the research team at pmccraken@optimal-mobility.com for enrollment information.

Where is the NCT07290556 trial being conducted?

This trial is being conducted at Saint Paul, United States.

Who is sponsoring the NCT07290556 clinical trial?

NCT07290556 is sponsored by Optimal Mobility, Inc. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology